Skip to content

PrediSurge vs Sim&Cure

PrediSurge logo

PrediSurge

Precision Medicine Platform for Cardiovascular Interventions

34 employees · est. 2017 · France

VS
Sim&Cure logo

Sim&Cure

Shaping the future of endovascular treatments. For more information about our products, visit our website!

67 employees · est. 2014 · Montpellier, France

Sim&Cure is the older company (2017 vs 2014); Sim&Cure is the larger of the two.

Side-by-Side Comparison

PrediSurge Sim&Cure
Founded
2017 2014 older
Headquarters
France Montpellier, France
Employees
34 67 larger
Industry
Health Care, Information Technology, Medical Devices Health Care, Medical Devices
Funding Stage
Series A Series A
Total Funding
$10.50M $3.00M
Funding Rounds
4 1
Services
PrediSurge develops precision medicine platform for cardiovascular interventions, creating patient-specific digital twins for numerical models simulating the biomechanical behavior of arteries and cardiac valves. Development and delivery of next-generation brain aneurysm treatment solutions through digital twin and AI technologies
Target Customers
The company's target customers and users include cardiovascular physicians, clinical specialists, and medical device companies seeking advanced tools for risk assessment and precision in endovascular procedures. Healthcare professionals, hospitals, and neurovascular specialists
Taxonomy
Precision MedicineCardiovascular InterventionsDigital SolutionsNumerical SimulationDecision SupportMedical Device Design +5 Medical SoftwarePatient-specificEndovascular TreatmentsInnovationNeurovascularDigital Twin +8
Website
predisurge.com sim-and-cure.com
PrediSurge logo

About PrediSurge

PrediSurge is a precision medicine platform that offers a novel approach for cardiovascular interventions. Founded in 2017, the company's technology leverages pre-operative imaging to create patient-specific digital twins, enabling physicians to simulate arteries and valves' biomechanical behavior....

Sim&Cure logo

About Sim&Cure

Sim&Cure is a French digital start-up founded in 2014, with a focus on revolutionizing endovascular treatments. The company's mission is to enhance patient outcomes and physician experiences through the utilization of Digital Twin and AI Technologies. Sim&Cure has received notable recognition, winni...

Also comparing in this category

Comparing more than these two?

Get PrediSurge, Sim&Cure and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does PrediSurge compare?

A PDF of PrediSurge and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

PrediSurge was founded in 2017, based in France, with 34 employees. PrediSurge is a precision medicine platform that offers a novel approach for cardiovascular interventions. Founded in 2017, the company's technology leverages pre-operative imaging to create patient-s. Sim&Cure was founded in 2014, based in Montpellier, France, with 67 employees. Sim&Cure is a French digital start-up founded in 2014, with a focus on revolutionizing endovascular treatments. The company's mission is to enhance patient outcomes and physician experiences through t.
PrediSurge has raised $10.50M and Sim&Cure $3.00M. Latest stage: PrediSurge Series A, Sim&Cure Series A.
Both work in Health Care and Medical Devices.

Compare PrediSurge with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at PrediSurge on 11 Jun 2025, and Sim&Cure on 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout